Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Breckenridge Pharmaceutical, Inc

02 2Breckenridge Pharmaceutical, Inc.

03 6Towa Pharmaceutical Europe, S.L.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

FDA Audited

USA

Breckenridge Pharmaceutical

City : Berlin

State : Connecticut

Country/Area : U.S.A

Zip : 6037

District :

Center :

Project Area : Bioresearch Monitoring

District Decision : No Action Indicated

Inspection End Date : 2024-01-05

Breckenridge Pharmaceutical

02

FDA Audited

USA

Breckenridge Pharmaceutical

City : Berlin

State : Connecticut

Country/Area : U.S.A

Zip : 6037

District :

Center :

Project Area : Bioresearch Monitoring

District Decision : No Action Indicated

Inspection End Date : 2024-01-05

Breckenridge Pharmaceutical

03

FDA Audited

USA

District Decision : Voluntary Action Indicated

Inspection End Date : 2022-09-09

Towa Pharmaceutical

City : Martorelles

State :

Country/Area : Spain

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2022-09-09

Towa Pharmaceutical

04

FDA Audited

USA

Breckenridge Pharmaceutical

City : Berlin

State : Connecticut

Country/Area : U.S.A

Zip : 6037

District :

Center :

Project Area : Bioresearch Monitoring

District Decision : No Action Indicated

Inspection End Date : 2019-01-29

Breckenridge Pharmaceutical

05

FDA Audited

USA

Breckenridge Pharmaceutical

City : Berlin

State : Connecticut

Country/Area : U.S.A

Zip : 6037

District :

Center :

Project Area : Bioresearch Monitoring

District Decision : No Action Indicated

Inspection End Date : 2019-01-29

Breckenridge Pharmaceutical

06

FDA Audited

USA

District Decision : No Action Indicated

Inspection End Date : 2019-01-18

Towa Pharmaceutical

City : Martorelles

State :

Country/Area : Spain

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2019-01-18

Towa Pharmaceutical

07

FDA Audited

USA

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-03-31

Towa Pharmaceutical

City : Martorelles

State :

Country/Area : Spain

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-03-31

Towa Pharmaceutical

08

FDA Audited

USA

Breckenridge Pharmaceutical

City : Berlin

State : Connecticut

Country/Area : U.S.A

Zip : 6037

District :

Center :

Project Area : Bioresearch Monitoring

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-02-21

Breckenridge Pharmaceutical

09

FDA Audited

USA

Breckenridge Pharmaceutical

City : Berlin

State : Connecticut

Country/Area : U.S.A

Zip : 6037

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2017-02-21

Breckenridge Pharmaceutical

10

FDA Audited

USA

District Decision : Voluntary Action Indicated

Inspection End Date : 2015-02-13

Towa Pharmaceutical

City : Martorelles

State :

Country/Area : Spain

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2015-02-13

Towa Pharmaceutical